SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes

被引：0
|
作者：
Davila, Esteban [1 ]
Mccormack, James [2 ]
机构：
[1] New York City Hlth Hosp Kings Cty, Dept Emergency Med, 451 Clarkson Ave, Brooklyn, NY 11203 USA
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
来源：
ACADEMIC EMERGENCY MEDICINE | 2024年 / 31卷 / 04期
关键词：
diabetes; GLP-1 receptor agonist; metformin; SGLT-2; inhibitor;
D O I：
10.1111/acem.14895
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：408 / 411
页数：4
相关论文
共 50 条
  • [1] GLP-1 receptor agonists in comparison with SGLT-2 inhibitors
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (05): : 530 - 531
  • [2] SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation
    Arnold, Michael J.
    Buelt, Andrew
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (06) : 675 - 677
  • [3] SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
    Li, Sheyu
    Vandvik, Per Olav
    Lytvyn, Lyubov
    Guyatt, Gordon H.
    Palmer, Suetonia C.
    Rodriguez-Gutierrez, Rene
    Foroutan, Farid
    Agoritsas, Thomas
    Siemieniuk, Reed A. C.
    Walsh, Michael
    Frere, Lawrie
    Tunnicliffe, David J.
    Nagler, Evi, V
    Manja, Veena
    Asvold, Bjorn Olav
    Jha, Viveekanand
    Vermandere, Mieke
    Gariani, Karim
    Zhao, Qian
    Ren, Yan
    Cartwright, Emma Jane
    Gee, Patrick
    Wickes, Alan
    Ferns, Linda
    Wright, Robin
    Li, Ling
    Hao, Qiukui
    Mustafa, Reem A.
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [4] Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists
    Jargin, Sergei V.
    EUROPEAN JOURNAL OF THERAPEUTICS, 2019, 25 (02): : 93 - 96
  • [5] GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns
    Dimitriadis, George D.
    Lambadiari, Vaia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : E52 - E53
  • [6] Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (06): : 329 - 342
  • [7] Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Vestergaard, Peter
    Bonde, Anders N.
    Fosbol, Emil
    Kober, Lars
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 549 - 556
  • [8] EFFICACY OF GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES IN LIVER TRANSPLANT RECIPIENTS
    Azhie, Amirhossein
    Gupta, Sarang
    Misra, Shruti
    Chen, Shiyi
    Meerasa, Ameena
    Dash, Satya
    Woo, Minna
    Bhat, Mamatha
    GASTROENTEROLOGY, 2022, 162 (07) : S753 - S753
  • [9] The evolution of type 2 diabetes management: glycemic control and beyond with SGLT-2 inhibitors and GLP-1 receptor agonists
    Serowik, Thomas C.
    Pantalone, Kevin M.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2024, 124 (03): : 127 - 135
  • [10] IMPACT OF GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Timkina, N.
    Simanenkova, A.
    Mart'Yanova, M.
    Karonova, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S460 - S460
12345